According to Baihua Pharmaceutical's announcement, the company's stock rose and fell for three consecutive trading days from August 4 to 6, 2026. The cumulative deviation value of increase reached 30.68%. The turnover rate on August 6 was 32.72%, and the 3-day cumulative turnover rate was 46.33%. The company's fundamentals have not changed, there have been no major changes in the main business, internal and external environment or policies, and there are no important matters that should be disclosed or not disclosed. Remind investors to pay attention to secondary market transaction risks, make rational decisions, and invest prudently.

According to Baihua Pharmaceutical's announcement, the company's stock rose and fell for three consecutive trading days from August 4 to 6, 2026. The cumulative deviation value of increase reached 30.68%. The turnover rate on August 6 was 32.72%, and the 3-day cumulative turnover rate was 46.33%. The company's fundamentals have not changed, there have been no major changes in the main business, internal and external environment or policies, and there are no important matters that should be disclosed or not disclosed. Remind investors to pay attention to secondary market transaction risks, make rational decisions, and invest prudently.